- Single Room System
- Multi-Room System
Proton Therapy Market size was valued at USD 454.14 million in 2022 and is expected to reach USD 1,084.90 million by 2029 at a CAGR of 11.5% during the forecast period 2023-2029. Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels protons can destroy the cancer cells. Proton therapy is a non-invasive procedure in which proton radiation used to treat cancer. Proton therapy is a type of external beam radiation therapy, that painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with the other treatments such as surgery, chemotherapy, general radiation therapy and or immunotherapy. The global proton therapy market is expected to grow at significant CAGR rates during the forecast period owing to the factors such as growing prevalence of cancer and adaptation of non-invasive techniques such as radiation therapy to treat the cancer tumors. For instance, in September 2017, Elekta and Ion Beam Applications (IBA) has entered into a collaboration to work closely together in software development as well as sales and marketing of each other products. Under the agreement, Companies seeks to develop a novel functionality for the proton therapy treatment in Monaco treatment planning system of Elekta and MOSAIQ oncology information system.
Fastest Growing Market
Global proton therapy market is mainly driven by an increase in the adaptation of non-invasive therapies in the treatment of cancer. In addition, growing number of radiation centers globally coupled with the increase in the prevalence of the cancer cases expected to fuel the market growth over the forecast period. Furthermore, proton therapy is more advantageous than the other radiation therapies. Proton therapy delivers up to 60% less radiation to healthy tissue around the tumor and has fewer side effects during and after the treatment. Based on above-mentioned factors global proton therapy market is expected to increase its traction over the forecast period. However, a high cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period.
The proton therapy market is projected to expand at a CAGR of 11.5% during the forecast period.
Mitsubishi Electric Corporation (Japan), Optivus Proton Therapy, Inc. (U.S.), Mevion Medical Systems (U.S.), Advanced Oncotherapy plc (U.K.), ProTom International Inc, (U.S.), ProNova Solutions LLC (U.S.)
Asia Pacific is the fastest-growing region for proton therapy market
Table of Content